1Kalra PR, Anker SD, Coats A.IS. Water and sodium regulation in chronic heart failure : The role of natriuretic peptides and vasopressin, Cardiovase Res ,2001,51 (2) :495
2Stein BC, Levin RI. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J ,1998,135(4) :914
3Dao Q,Krishnaswamy P, Kazanegra B, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol,2001,37 ( 1 ) :379
4Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet, 1994,343 (2) :440
5Keating GM, Goat KL. Nesiritide : A review of its use in acute decompensated heart failure. Drugs,2003,63 (3) :47
7Burger AJ, Horton DP, LeJemtel T, et al. The effect of nesiritide and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congetive heart failure: The PRECEDENT study. Am Heart ,2002,144(2) :1102
